TRAC Seminar Series
The Tuberculosis Research Advancement Center (TRAC) Seminar will resume for the 2025-2026 academic year on Wednesday, September 3, 2025 from 12:00 – 1:00 PM ET in the Carnegie 328 Conference Room and via Zoom. Add to Calendar.
**Please note that unfortunately we will no longer be able to provide lunch during these meetings**
“Clinical Impact of NAT2 Testing, Therapeutic Drug Monitoring, and Dose-Intensification on TB Treatment Outcomes”
Jeffrey A. Tornheim, MD, MPH
Associate Professor of Medicine, Pediatrics and International Health
Johns Hopkins University School of Medicine
Jeffrey A. Tornheim, MD, MPH, is an Associate Professor of Medicine and Pediatrics at the Johns Hopkins University School of Medicine as well as a TB clinician at the Baltimore City Health Department. His research explores the application of new diagnostic technologies including bacterial next generation sequencing, multiomic host biomarkers, and both individual- and population-level pharmacologic assessments to improved health outcomes in the treatment of drug resistant tuberculosis among both adult and pediatric patients. His active projects include cohort studies of individualized dosing for people with both drug-susceptible and drug-resistant tuberculosis.
The September TRAC seminars are presented by the Clinical Core and will focus on Domestic TB. The September seminars will be held in-person in the Carnegie 328 Conference Room and via Zoom.
Join via Zoom: New link for 2025-2026
Topic: TRAC Seminar Series
Time: Every week on Wednesday at 12:00 PM Eastern Time (US and Canada)
https://jhjhm.zoom.us/j/94704979755?pwd=YpHbpfn2jpsUhPl2DVXtYsehDQSrMP.1
Meeting ID: 947 0497 9755
Passcode: 179967